About
OraSure Technologies develops, manufactures, and distributes oral fluid diagnostic and collection devices, and other technologies designed to detect or diagnose critical medical conditions. It offers its products to clinical laboratories, hospitals, clinics, community-based organizations, and other public health organizations as well as research and academic institutions, distributors, government agencies, physicians’ offices, and commercial and industrial entities. The company offers include point-of-care diagnostic products, oral fluid specimen collection devices that leverage proprietary oral fluid technologies, laboratory diagnostic products such as immunoassays and other in vitro diagnostic tests, and other medical devices. Its line of products include tests for the detection of antibodies to the HIV virus, including the OraQuick In-Home HIV Test, OraQuick ADVANCE Rapid HIV-1/2 Antibody Test, and the OraSure HIV-1 Oral Specimen Collection Device; a test for antibodies to the HCV
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 13 investors are based in Bethlehem, Pennsylvania, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Bethlehem, US
Contact Information
Find more investors like OraSure
Search Investors